These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Kuntz JL; Johnson ES; Raebel MA; Petrik AF; Yang X; Thorp ML; Spindel SJ; Neil N; Smith DH Infect Control Hosp Epidemiol; 2012 Oct; 33(10):1031-8. PubMed ID: 22961023 [TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Kociolek LK; Patel SJ; Shulman ST; Gerding DN Infect Control Hosp Epidemiol; 2015 Apr; 36(4):445-51. PubMed ID: 25782900 [TBL] [Abstract][Full Text] [Related]
8. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection. Richardson C; Kim P; Lee C; Bersenas A; Weese JS Anaerobe; 2015 Jun; 33():105-8. PubMed ID: 25769665 [TBL] [Abstract][Full Text] [Related]
10. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan. Fukuda H; Yano T; Shimono N Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794 [TBL] [Abstract][Full Text] [Related]
12. Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model. Stevens VW; Khader K; Nelson RE; Jones M; Rubin MA; Brown KA; Evans ME; Greene T; Slade E; Samore MH Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1024-30. PubMed ID: 26006153 [TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive care. Zilberberg MD; Shorr AF; Micek ST; Kollef MH Infect Control Hosp Epidemiol; 2015 Mar; 36(3):273-9. PubMed ID: 25695168 [TBL] [Abstract][Full Text] [Related]
14. Impact of hospital-acquired Clostridium difficile. Lipp MJ; Nero DC; Callahan MA J Gastroenterol Hepatol; 2012 Nov; 27(11):1733-7. PubMed ID: 22849881 [TBL] [Abstract][Full Text] [Related]
15. Vital signs: preventing Clostridium difficile infections. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(9):157-62. PubMed ID: 22398844 [TBL] [Abstract][Full Text] [Related]
16. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732 [TBL] [Abstract][Full Text] [Related]
18. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery. Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110 [TBL] [Abstract][Full Text] [Related]
19. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study. Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532 [TBL] [Abstract][Full Text] [Related]
20. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. Zhang D; Prabhu VS; Marcella SW Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]